US and Russia sign deal. Watch CLDX hit $26 next week.
Rockefeller University (Rockefeller) – Celldex has licensed intellectual property from Rockefeller to target the DEC-205 family of mannose receptors in human dendritic cells, leveraging discoveries from the laboratories of the late Nobel Laureate Professor Ralph Steinman and Professor Michel Nussenzweig. Celldex is also collaborating with Rockefeller to develop CDX-2401, a novel vaccine against HIV, the virus known to cause AIDS. This project is supported through a grant from the Bill & Melinda Gates Foundation and utilizes human antibodies to DEC-205 receptors to selectively generate robust immune responses against specifically selected HIV antigens.
Weight, I doubt the HIV vaccine has any value. Celldex doesn't even tout it on the company website. Best not to mention it anymore. Celldex has so many other truly promising treatments that are being advanced and are nearing approval. Call attention to those. Publicizing a loser doesn't help the company's share price.
I noticed your post plugging CLDX on the VPHM board.